by on November 28, 2023
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has launched a range of antibodies, antigens and kits against CLDN6 to support researchers worldwide in preclinical and clinical safety/efficacy testing. CLDN6 may be involved in the development and progression of many malignancies, including breast cancer, gastric cancer and hepatocellular carcinoma (HCC). Several members of the claudin (CLDN) family are located at tight junctions between epithe...
73 views 0 likes